Nyxoah s.a.NYXH.US Overview

US StockHealthcare

(No presentation for NYXH)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

NYXH Overall Performance

NYXH AI Analysis & Strategy

NYXH Recent Performance

2.23%

Nyxoah s.a.

0.81%

Avg of Sector

-1.14%

S&P500

NYXH PowerScanner

NYXH Key Information

NYXH Valuation Metrics

NYXH Earnings Table

NYXH Profile

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.